Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |